SN-38 is a highly potent topoisomerase I inhibitor and is the active moiety of the marketed anticancer drug irinotecan (CPT-11). Irinotecan is widely used, mainly for colorectal cancer ...

SNB-101 is an innovative anticancer drug, marking the world's first nanoparticle formulation of SN-38, the active metabolite of irinotecan. Utilizing SN BioScience's dual nano-micelle delivery ...